Cystic Fibrosis Foundation - May 15, 2024 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
10%+ Owner
Signature
/s/ Ania Howell
Stock symbol
PHGE
Transactions as of
May 15, 2024
Transactions value $
$4,778
Form type
4
Date filed
5/17/2024, 04:05 PM
Previous filing
Mar 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $4.78K +4.78M +104.96% $0.00* 9.33M May 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Warrant to purchase common stock Exercise of in-the-money or at-the-money derivative security $0 -4.78M -100% $0.00* 0 May 15, 2024 Common stock 4.78M $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrant was exercisable beginning on February 27, 2023, for that number of shares that would not result in the Reporting Person beneficially owning more than 9.99% of the number of shares of common stock then issued and outstanding upon such exercise, and became exercisable in full on May 15, 2024. The warrant does not expire.